A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection.
Visentini M, Ludovisi S, Petrarca A, Pulvirenti F, Zaramella M, Monti M, Conti V, Ranieri J, Colantuono S, Fognani E, Piluso A, Tinelli C, Zignego AL, Mondelli MU, Fiorilli M, Casato M.
Visentini M, et al. Among authors: piluso a.
Autoimmun Rev. 2011 Sep;10(11):714-9. doi: 10.1016/j.autrev.2011.04.033. Epub 2011 May 5.
Autoimmun Rev. 2011.
PMID: 21570494
Clinical Trial.